198 related articles for article (PubMed ID: 27046439)
1. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes.
Oorts M; Baze A; Bachellier P; Heyd B; Zacharias T; Annaert P; Richert L
Toxicol In Vitro; 2016 Aug; 34():179-186. PubMed ID: 27046439
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.
Chatterjee S; Richert L; Augustijns P; Annaert P
Toxicol Appl Pharmacol; 2014 Jan; 274(1):124-36. PubMed ID: 24211272
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture.
Oorts M; Richert L; Annaert P
J Pharmacol Toxicol Methods; 2015; 73():63-71. PubMed ID: 25828992
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
[TBL] [Abstract][Full Text] [Related]
5. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.
Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214
[TBL] [Abstract][Full Text] [Related]
6. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
[TBL] [Abstract][Full Text] [Related]
7. Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes.
Deferm N; Richert L; Van Brantegem P; De Vocht T; Qi B; de Witte P; Bouillon T; Annaert P
Methods Mol Biol; 2019; 1981():335-350. PubMed ID: 31016665
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acids.
Koga T; Takeuchi K; Umehara K
J Toxicol Sci; 2023; 48(1):47-56. PubMed ID: 36599427
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced cholestasis assay in primary hepatocytes.
Van Brantegem P; Chatterjee S; De Bruyn T; Annaert P; Deferm N
MethodsX; 2020; 7():101080. PubMed ID: 33088729
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats.
Richert L; Baze A; Parmentier C; Gerets HHJ; Sison-Young R; Dorau M; Lovatt C; Czich A; Goldring C; Park BK; Juhila S; Foster AJ; Williams DP
Toxicol Lett; 2016 Sep; 258():207-215. PubMed ID: 27363785
[TBL] [Abstract][Full Text] [Related]
11. Rat precision-cut liver slices predict drug-induced cholestatic injury.
Starokozhko V; Greupink R; van de Broek P; Soliman N; Ghimire S; de Graaf IAM; Groothuis GMM
Arch Toxicol; 2017 Oct; 91(10):3403-3413. PubMed ID: 28391356
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes.
Parmentier C; Couttet P; Wolf A; Zaccharias T; Heyd B; Bachellier P; Uteng M; Richert L
Arch Toxicol; 2017 Aug; 91(8):2879-2893. PubMed ID: 28188341
[TBL] [Abstract][Full Text] [Related]
13. An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes.
Ansede JH; Smith WR; Perry CH; St Claire RL; Brouwer KR
Drug Metab Dispos; 2010 Feb; 38(2):276-80. PubMed ID: 19910518
[TBL] [Abstract][Full Text] [Related]
14. Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.
Sakai Y; Okumura H; Iwao T; Watashi K; Ito K; Matsunaga T
Toxicol In Vitro; 2019 Dec; 61():104619. PubMed ID: 31394163
[TBL] [Abstract][Full Text] [Related]
15. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.
Ogimura E; Sekine S; Horie T
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):313-7. PubMed ID: 22108051
[TBL] [Abstract][Full Text] [Related]
16. In vitro bile acid-dependent hepatocyte toxicity assay system using human induced pluripotent stem cell-derived hepatocytes: Current status and disadvantages to overcome.
Sakai Y; Iwao T; Susukida T; Nukaga T; Takemura A; Sekine S; Ito K; Matsunaga T
Drug Metab Pharmacokinet; 2019 Aug; 34(4):264-271. PubMed ID: 31285099
[TBL] [Abstract][Full Text] [Related]
17. Predicting drug-induced cholestasis: preclinical models.
Petrov PD; Fernández-Murga ML; López-Riera M; Goméz-Lechón MJ; Castell JV; Jover R
Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):721-738. PubMed ID: 29888962
[TBL] [Abstract][Full Text] [Related]
18. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients.
López-Riera M; Conde I; Castell JV; Jover R
Toxicol Sci; 2020 Feb; 173(2):229-243. PubMed ID: 31198949
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic Analysis of Cholestatic Compounds In Vitro.
Parmentier C; Couttet P; Uteng M; Wolf A; Richert L
Methods Mol Biol; 2019; 1981():175-186. PubMed ID: 31016655
[TBL] [Abstract][Full Text] [Related]
20. Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes.
Oorts M; Van Brantegem P; Deferm N; Chatterjee S; Dreesen E; Cooreman A; Vinken M; Richert L; Annaert P
J Pharmacol Exp Ther; 2021 Oct; 379(1):20-32. PubMed ID: 34349015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
